1
|
Demoor-Goldschmidt C, Veillon P, Esvan M, Leonard M, Chauvet S, Bertrand A, Carausu L, Delehaye F, Lejeune J, Rouger J, Schneider P, Thomas C, Millot F, Claude L, Leseur J, Missohou F, Supiot S, Bihannic N, Debroise I, Jeanneaud C, Lebreton E, Roumy M, Aguerris L, Chrétien JM, Gandemer V, Pellier I. A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility. BMC Cancer 2024; 24:130. [PMID: 38267891 PMCID: PMC10809785 DOI: 10.1186/s12885-024-11857-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2023] [Accepted: 01/08/2024] [Indexed: 01/26/2024] Open
Abstract
BACKGROUND Treatment summaries and a personalized survivorship care plans based on internationally approved, organ-specific follow-up care recommendations are essential in preserving the health and quality of life for cancer survivors. Cohorts made up of survivors of childhood cancer have made significant contributions to the understanding of early mortality, somatic late complications, and psychosocial outcomes among former patients. New treatment protocols are needed to enhance survival and reduce the potential risk and severity of late effects, and working with treatment databases is crucial in doing so. CONSTRUCTION AND CONTENT In the GOCE (Grand Ouest Cancer de l'Enfant [Western Region Childhood Cancer]) network, in a participative approach, we developed the LOG-after medical tool, on which health data are registered and can be extracted for analysis. Its name emphasizes the tool's goal, referring to 'logiciel' (the French word for software) that focuses on the period "after" the acute phase. This tool is hosted on a certified health data server. Several interfaces have been developed that can be used depending on the user's profile. Here we present this innovative co-constructed tool that takes national aspects into account, including the results of the feasibility/satisfaction study and its perspective. UTILITY AND DISCUSSION The database contains data relating to 2558 patients, with samples from 1702 of these (66.54%) being held in a tumor bank. The average year in which treatment started was 2015 (ranging from December 1967 to November 2022: 118 patients were treated before 2012 and registered retrospectively when seen in long-term follow-up consultations or for another cancer since November 2021). A short questionnaire was distributed to healthcare professionals using the tool (physicians and research associates or technicians, n = 14), of whom 11 answered and were all satisfied. Access to the patient interface is currently open to 124 former patients. This was initially offered to 30 former patients who were over 15 years old, affected by the disease within the last 5 years, and had agreed to test it. Their opinions were collected by their doctor by e-mail, telephone, or during a consultation in an open-ended question and a non-directive interview. All patients were satisfied with the tool, with interest in testing it in the long term. Some former patients found that the tool provided them with some ease of mind; one, for instance, commented: "I feel lighter. I allow myself to forget. I know I will get a notification when the time comes." CONCLUSIONS Freely available to all users, LOG-after: (1) provides help with determining personalized survivorship care plans for follow-up; (2) builds links with general practitioners; (3) empowers the patient; and (4) enables health data to be exported for analysis. Database URL for presentation: https://youtu.be/2Ga64iausJE.
Collapse
Affiliation(s)
- Charlotte Demoor-Goldschmidt
- Department of Oncohematopediatrics, University Hospital of Angers, University of Angers, Angers, France.
- Department of Radiotherapy, Centre François Baclesse, University of Caen, Caen, France.
- Department of Supportive Care, Centre François Baclesse, University of Caen, Caen, France.
- Inserm U 1018, Epidemiology of Radiation, Gustave Roussy, Villejuif, France.
| | - Pascal Veillon
- Department of Oncohematopediatrics, University Hospital of Angers, University of Angers, Angers, France
| | - Maxime Esvan
- Department of Biostatitics, University Hospital of Rennes, Rennes, France
| | - Mathilde Leonard
- Department of Biostatitics, University Hospital of Rennes, Rennes, France
| | - Sophie Chauvet
- Department of Oncohematopediatrics, University Hospital of Nantes, Nantes, France
| | | | - Liana Carausu
- Department of Oncohematopediatrics, University Hospital of Brest, Brest, France
| | - Fanny Delehaye
- Department of Oncohematopediatrics, University Hospital of Caen, Caen, France
| | - Julien Lejeune
- Department of Oncohematopediatrics, University Hospital of Tours, Tours, France
| | - Jérémie Rouger
- Department of Oncohematopediatrics, University Hospital of Caen, Caen, France
| | - Pascale Schneider
- Department of Oncohematopediatrics, University Hospital of Rouen, Rouen, France
| | - Caroline Thomas
- Department of Oncohematopediatrics, University Hospital of Nantes, Nantes, France
| | - Frédéric Millot
- Department of Oncohematopediatrics, University Hospital of Poitiers, Poitiers, France
| | - Line Claude
- Department of Radiotherapy, Centre Leon Berard, Lyon, France
| | - Julie Leseur
- Department of Radiotherapy, Centre Eugène Marquis, Rennes, France
| | - Fernand Missohou
- Department of Radiotherapy, Centre François Baclesse, University of Caen, Caen, France
| | - Stéphane Supiot
- Department of Radiotherapy, Institut de Cancérologie de L'Ouest, Nantes, France
| | - Nathalie Bihannic
- Department of Oncohematopediatrics, University Hospital of Brest, Brest, France
| | | | - Carole Jeanneaud
- Department of Oncohematopediatrics, University Hospital of Tours, Tours, France
| | - Esther Lebreton
- Department of Oncohematopediatrics, University Hospital of Caen, Caen, France
| | - Marianne Roumy
- Department of Oncohematopediatrics, University Hospital of Angers, University of Angers, Angers, France
| | | | - Jean-Marie Chrétien
- Data Science Department, Clinical and Innovation Direction, CHU Angers, Angers, France
| | - Virginie Gandemer
- Department of Oncohematopediatrics, University Hospital of Rennes, Rennes, France
| | - Isabelle Pellier
- Department of Oncohematopediatrics, University Hospital of Angers, University of Angers, Angers, France
| |
Collapse
|
2
|
Delehaye F, Deparis M, Buchbinder N, Bodet D, Minard V, Jean-Jacques B, Marie-Laure Q, Gaulard P, Sako N, Robe C, Bardet H, Damaj G, Rouger J. Successful allogeneic hematopoietic stem cell transplantation in a child with angioimmunoblastic T-cell lymphoma: A case report. Pediatr Blood Cancer 2023; 70:e30497. [PMID: 37335263 DOI: 10.1002/pbc.30497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 06/02/2023] [Accepted: 06/05/2023] [Indexed: 06/21/2023]
Affiliation(s)
- Fanny Delehaye
- Department of Pediatric Oncology and Hematology, University Hospital of Caen, Normandy, Caen, France
- University of Caen, Normandy, Caen, France
| | - Marianna Deparis
- Department of Pediatric Oncology and Hematology, University Hospital of Caen, Normandy, Caen, France
| | - Nimrod Buchbinder
- Department of Pediatric Oncology and Hematology, University Hospital of Rouen, Normandy, Rouen, France
| | - Damien Bodet
- Department of Pediatric Oncology and Hematology, University Hospital of Caen, Normandy, Caen, France
| | - Véronique Minard
- Department of Pediatric Oncology, Gustave Roussy Institute, VilleJuif, France
| | | | | | - Philippe Gaulard
- Department of Pathology, Hôpital Henri Mondor APHP, Créteil, France
| | - Nouhoum Sako
- Department of Pathology, Hôpital Henri Mondor APHP, Créteil, France
| | - Cyrielle Robe
- Department of Pathology, Hôpital Henri Mondor APHP, Créteil, France
| | - Hippolyte Bardet
- Department of Hematology, University Hospital of Caen, Caen, France
| | - Gandhi Damaj
- Department of Hematology, University Hospital of Caen, Caen, France
| | - Jérémie Rouger
- Department of Pediatric Oncology and Hematology, University Hospital of Caen, Normandy, Caen, France
- University of Caen, Normandy, Caen, France
| |
Collapse
|
3
|
Delehaye F, Damien B, Anne D, Céline B, Andreea A, Thierry P, Julien R. Unusual recurrence of sacrococcygeal mature teratoma: A case report. Pediatr Blood Cancer 2023; 70:e30048. [PMID: 36215198 DOI: 10.1002/pbc.30048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Revised: 09/14/2022] [Accepted: 09/19/2022] [Indexed: 11/07/2022]
Affiliation(s)
- Fanny Delehaye
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| | - Bodet Damien
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| | - Dompmartin Anne
- Department of Dermatology, University Hospital of Caen, Caen, France
| | - Bazille Céline
- Department of Pathology, University Hospital of Caen, Caen, France
| | - Apetrei Andreea
- Department of Genetics, University Hospital of Caen, Caen, France
| | - Petit Thierry
- Department of Pediatric Surgery, University Hospital of Caen, Caen, France
| | - Rod Julien
- Department of Pediatric Surgery, University Hospital of Caen, Caen, France
| |
Collapse
|
4
|
Delehaye F, Sarnacki S, Orbach D, Cheikhelard A, Rouger J, Parienti JJ, Faure-Conter C, Hameury F, Dijoud F, Aubry E, Wacrenier A, Habonimana E, Duchesne C, Joseph S, Alliot H, Scalabre A, Chaussy Y, Podevin G, Croue A, Haraux E, Guibal MP, Pommepuy I, Ballouhey Q, Lavrand F, Peycelon M, Irtan S, Guerin F, Dariel A, Borionne C, Galmiche L, Rod J. Lessons from a large nationwide cohort of 350 children with ovarian mature teratoma: A study in favor of ovarian-sparing surgery. Pediatr Blood Cancer 2022; 69:e29421. [PMID: 34842332 DOI: 10.1002/pbc.29421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 10/01/2021] [Accepted: 10/05/2021] [Indexed: 11/06/2022]
Abstract
BACKGROUND Ovarian mature teratoma (OMT) is a common ovarian tumor found in the pediatric population. In 10%-20% of cases, OMT occurs as multiple synchronous or metachronous lesions on ipsi- or contralateral ovaries. Ovarian-sparing surgery (OSS) is recommended to preserve fertility, but total oophorectomy (TO) is still performed. DESIGN This study reviews the clinical data of patients with OMT, and analyzes risk factors for second events. A national retrospective review of girls under 18 years of age with OMTs was performed. Data on clinical features, imaging, laboratory studies, surgical reports, second events and their management were retrieved. RESULTS Overall, 350 children were included. Eighteen patients (5%) presented with a synchronous bilateral form at diagnosis. Surgery was performed by laparotomy (85%) and laparoscopy (15%). OSS and TO were performed in 59% and 41% of cases, respectively. Perioperative tumor rupture occurred in 23 cases, independently of the surgical approach. Twenty-nine second events occurred (8.3%) in a median time of 30.5 months from diagnosis (ipsilateral: eight cases including one malignant tumor; contralateral: 18 cases; both ovaries: three cases). A large palpable mass, bilateral forms, at diagnosis and perioperative rupture had a statistical impact on the risk of second event, whereas the type of surgery or approach did not. CONCLUSION This study is a plea in favor of OSS as the first-choice treatment of OMT when possible. Close follow-up during the first 5 years is mandatory considering the risk of 8.3% of second events, especially in cases with risk factors.
Collapse
Affiliation(s)
- Fanny Delehaye
- Department of Pediatric Haematology and Oncology, University Hospital of Caen, 14000, Caen, France
| | - Sabine Sarnacki
- Department of Pediatric Surgery, Université de Paris, Hôpital Necker Enfants-Malades, Assistance Publique - Hôpitaux de Paris, Paris, France
| | - Daniel Orbach
- SIREDO Oncology Centre (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France
| | - Alaa Cheikhelard
- Department of Pediatric Surgery, Université de Paris, Hôpital Necker Enfants-Malades, Assistance Publique - Hôpitaux de Paris, Paris, France.,National Reference Centre for Rare Gynecological Diseases (PGR), Paris, France
| | - Jérémie Rouger
- Department of Pediatric Haematology and Oncology, University Hospital of Caen, 14000, Caen, France
| | - Jean-Jacques Parienti
- Department of Biostatistics and Clinical Research, University Hospital of Caen Normandy, Caen, France
| | - Cécile Faure-Conter
- Centre Leon Bernard, Pediatric Hemato-Oncology Institute (IHOPe), Lyon, France
| | - Frédéric Hameury
- Pediatric Surgery Department, Femme-Mère-Enfant University Hospital, 59, boulevard Pinel, 69677, Bron, France
| | - Frédérique Dijoud
- Anatomy-Cytology-Pathology Department, Women-Mother and Child Hospital, Hospices Civils de Lyon, Lyon, France
| | - Estelle Aubry
- CHU Lille, Centre de Référence du Développement Génital DEV GEN, Service de Chirurgie Pédiatrique, Hôpital Jeanne de Flandres, 59000, Lille, France
| | - Agnès Wacrenier
- Anatomy-Cytology-Pathology Department, CHU Lille, Lille, France
| | - Edouard Habonimana
- Department of Pediatric Surgery, Rennes University Hospital, Rennes, France
| | - Camille Duchesne
- Department of Pediatric Surgery, Rennes University Hospital, Rennes, France
| | - Solène Joseph
- Department of Pediatric Surgery, CHU de Nantes, Hôtel-Dieu, 1, Place Alexis-Ricordeau, 44000, Nantes, France
| | - Hortense Alliot
- Department of Pediatric Surgery, CHU de Nantes, Hôtel-Dieu, 1, Place Alexis-Ricordeau, 44000, Nantes, France
| | - Aurélien Scalabre
- Department of Pediatric Surgery, University Hospital of Saint-Etienne, CHU de Saint-Etienne Hôpital Nord, Saint-Etienne Cedex 2, France
| | - Yann Chaussy
- Paediatric Surgery Department, University Hospital of Besancon, Besancon, France
| | - Guillaume Podevin
- Paediatric Surgery Department, Angers University Hospital, Angers, France
| | - Anne Croue
- Anatomy-Cytology-Pathology Department, Centre Hospitalier Universitaire d'Angers, Angers, France
| | - Elodie Haraux
- Paediatric Surgery Department, Amiens University Hospital, Amiens, France
| | - Marie Pierre Guibal
- Department of Pediatric Surgery, University Hospital of Montpellier, Montpellier, France
| | - Isabelle Pommepuy
- Service d'anatomie Pathologique, CHU Dupuytren, 2, Avenue Martin-Luther-King, 87042, Limoges Cedex, France
| | - Quentin Ballouhey
- Department of Pediatric Surgery, Hôpital des Enfants, 8 Avenue Dominique Larrey, 87042, Limoges Cedex, France
| | - Frédéric Lavrand
- Department of Pediatric Surgery, Groupe Hospitalier Pellegrin, Hôpital d'enfants, Bordeaux, France
| | - Matthieu Peycelon
- AP-HP, Hôpital Universitaire Robert-Debré, Pediatric Urology Department, Reference Center for Rare Diseases (CRMR), Malformations Rares des Voies Urinaires (MARVU), Université de Paris, Paris, France
| | - Sabine Irtan
- Paediatric Surgery Department, Trousseau Hospital - Assistance Publique des Hôpitaux de Paris, Paris, France
| | - Florent Guerin
- Paediatric Surgery Department, Groupement Hospitalier Paris Sud (GHUPS), Hôpital Bicêtre, Le Kremlin-Bicetre, France
| | - Anne Dariel
- Pediatric Surgery Department, Hôpital d'enfants de la Timone, Marseille, France
| | - Claude Borionne
- Pediatric Surgery Department, Hôpital d'enfants de la Timone, Marseille, France
| | - Louise Galmiche
- Pathology Department, CHU de Nantes, Hôtel-Dieu, 1, Place Alexis-Ricordeau, 44000, Nantes, France
| | - Julien Rod
- Department of Pediatric Surgery, University Hospital of Caen, Avenue de la Côte de Nacre, 14000, Caen, France.,Laboratory INSERM U1086, ANTICIPE, Centre François Baclesse, Caen, France
| |
Collapse
|
5
|
Delehaye F, Habes D, Dourthe ME, Bertrand Y, Michel G, Gaudichon J, Debray D, Nelken B, Pasquet M, Blanche S, Leblanc T. Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey. Pediatr Blood Cancer 2020; 67:e28177. [PMID: 31925926 DOI: 10.1002/pbc.28177] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2019] [Revised: 12/18/2019] [Accepted: 12/21/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Hepatitis-associated aplastic anemia (AA) is a rare syndrome combining acute hepatitis of variable severity and AA. Hepatitis may be severe enough to require urgent liver transplantation (LT). Herein, we describe clinical presentation and management of a cohort of pediatric patients diagnosed with AA after undergoing LT for nonviral hepatitis. METHODS To describe this rare clinical situation, we performed a national survey and identified nine children treated for AA following LT during the last 10 years in France. RESULTS All patients were treated first for hepatic failure with urgent LT. AA was diagnosed with a median delay of 34 days [21-200] from the diagnosis of hepatitis. Seven children were treated with antithymocyte globulin/cyclosporine, one with CSA alone and one received bone marrow transplantation. At the last visit (median follow-up: 4 years), outcomes were excellent: all patients were alive and in hematological remission (complete remission: 7; partial remission: 2). Immunosuppressive therapy was pursued in all patients due to the liver transplant. No unusual toxicities were reported. CONCLUSION AA after LT is considered a therapeutic challenge. Nevertheless, hematological outcome is good using a standard immunosuppressive approach.
Collapse
Affiliation(s)
- Fanny Delehaye
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| | - Dalila Habes
- Department of Pediatric Hepatology, AP-HP, Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France
| | - Marie-Emilie Dourthe
- Department of Pediatric Hematology and Immunology, AP-HP, Robert-Debré Hospital, Paris, France
| | - Yves Bertrand
- Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, University Claude Bernard Lyon 1, Lyon, France
| | - Gerard Michel
- Department of Pediatric Hematology and Oncology and Research Unit EA 3279, Timone Enfants Hospital and Aix-Marseille University, Marseille, France
| | - Jérémie Gaudichon
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| | - Dominique Debray
- Unit of Pediatric Hepatology, Reference Center for Rare Pediatric Liver Diseases, Necker-Enfants-Malades University Hospital, Paris, France.,Department of medicine, University of Paris-Descartes, Sorbonne Paris-Cité, Paris, France
| | - Brigitte Nelken
- Department of Pediatric Hematology-Oncology, Jeanne de Flandre Hospital, CHRU, Lille, France
| | - Marlène Pasquet
- Department of Pediatric Hematology and Oncology, University hospital of Toulouse, Toulouse, France
| | - Stéphane Blanche
- Department of Pediatric Hematology, Immunology and Rheumatology, AP-HP, Necker Enfants-Malades Hospital, Paris, France
| | - Thierry Leblanc
- Department of Pediatric Hematology and Immunology, AP-HP, Robert-Debré Hospital, Paris, France
| |
Collapse
|
6
|
Delehaye F, Villarbu M, Salaun V, Bracquemart C, Goyer I, Bodet D. Psychiatric manifestation and pancytopenia during a sickle cell vaso-occlusive crisis: An unusual etiology. Pediatr Blood Cancer 2019; 66:e27758. [PMID: 31006965 DOI: 10.1002/pbc.27758] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Revised: 03/25/2019] [Accepted: 03/26/2019] [Indexed: 11/07/2022]
Affiliation(s)
- Fanny Delehaye
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| | | | - Véronique Salaun
- Laboratory of Hematology, University Hospital of Caen, Caen, France
| | | | - Isabelle Goyer
- Department of Pharmacy, University Hospital of Caen, Caen, France
| | - Damien Bodet
- Department of Pediatric Hematology and Oncology, University Hospital of Caen, Caen, France
| |
Collapse
|